Search filters

List of works by Henrik Boye Jensen

4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review

scientific article

Association of myasthenia gravis with polymorphisms in the gene of histamine N-methyltransferase.

scientific article published on 7 August 2013

Can aerobic exercise alleviate flu-like symptoms following interferon beta-1a injections in patients with multiple sclerosis?

scientific article

Changes in cognition, arm function and lower body function after slow-release Fampridine treatment.

scientific article published on 22 May 2014

Correction: Langeskov-Christensen, M., et al. Aerobic Capacity Is Not Associated with Most Cognitive Domains in Patients with Multiple Sclerosis-A Cross-Sectional Investigation. Journal of Clinical Medicine 2018, 7, 272

scientific article published on 26 April 2019

Distribution-based estimates of minimum clinically important difference in cognition, arm function and lower body function after slow release-fampridine treatment of patients with multiple sclerosis.

scientific article

Effect of slow release-Fampridine on muscle strength, rate of force development, functional capacity and cognitive function in an enriched population of MS patients. A randomized, double blind, placebo controlled study.

scientific article published on 14 September 2016

Efficacy of high-intensity aerobic exercise on brain MRI measures in multiple sclerosis

scientific article published on 01 December 2020

High treatment adherence, satisfaction, motivation, and health-related quality of life with fingolimod in patients with relapsing-remitting multiple sclerosis – results from a 24-month, multicenter, open-label Danish study.

scientific article published on 29 June 2018

The six-spot-step test - a new method for monitoring walking ability in patients with chronic inflammatory polyneuropathy.

scientific article published on 13 April 2017

[Aminopyridines for symptomatic treatment of multiple sclerosis]

scientific article published on 01 December 2011

[CADASIL versus multiple sclerosis]

scientific article published on 01 February 2006

[There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis]